April 28 (Reuters) - Diagnostic Medical Systems SA
ALDMS.PA :
* 2022 ANNUAL RESULTS
* FY NET LOSS GROUP SHARE EUR 6.8 MILLION VERSUS LOSS EUR
3.9
MILLION YEAR AGO
* RESTATED EBITDA: €2.5M - RESTATED EBITDA MARGIN OF 7.0%
(VERSUS.
4.2% IN 2021)
* FY REVENUE EUR 35.3 MILLION VERSUS EUR 36.3 MILLION YEAR
AGO
* €4.4 MILLION IN AVAILABLE CASH AT THE END OF 2022
* CONFIRMATION OF 2023 OBJECTIVES
* CONFIRMS THE IMPROVEMENT IN ITS PROFITABILITY IN 2023,
WITH AN
EXPECTED INCREASE OF ITS EBITDA MARGIN
* IN 2027, ON THE HORIZON OF THE IMAGING 2027 PLAN, DMS
GROUP HAS
SET ITSELF OBJECTIVES OF ACHIEVING A TURNOVER OF AT LEAST EUR 60
MILLION AND AN EBITDA MARGIN OF 14%
* CONFIRMS ITS OBJECTIVE OF CONSOLIDATED REVENUE OF €40
MILLION
Source text for Eikon: ID:nACT79607
Further company coverage: ALDMS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))